Breaking Finance News

Milacron Holdings Corp (NYSE:MCRN) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has upgraded Milacron Holdings Corp (NYSE:MCRN) to Hold in a statement released on 10/3/2016.

Having a price of $15.96, Milacron Holdings Corp (NYSE:MCRN) traded 0.50% higher on the day. With the last stock price down -0.30% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. MCRN has recorded a 50-day average of $16.17 and a two hundred day average of $16.09. Trade Volume was up over the average, with 92,164 shares of MCRN changing hands over the typical 82,255

Recent Performance Chart

Milacron Holdings Corp (NYSE:MCRN)

Milacron Holdings Corp has PE ratio of 41.13 with a one year low of $11.56 and a one year high of $19.07 and has a market capitalization of $0.

General Company Details For Milacron Holdings Corp (NYSE:MCRN)

Milacron Holdings Corp. is engaged in the manufacture, distribution, and service of engineered and customized systems used in the plastic technology and processing industry. The Company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids). The APPT segment is engaged in the manufacture, distribution and service of equipment and products used in the plastic technology and processing industry, including injection molding, blow molding and extrusion applications. The MDCS segment is engaged in the manufacture of plastic delivery and precision control systems, which are recurring, consumable sales for injection molding applications. The Fluids segment is engaged in the manufacture of coolants, lubricants, process cleaners and corrosion inhibitors that are used in a range of metalworking industries, such as cutting, grinding, stamping and forming and high speed machining.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *